Bisphosphonates and RANKL inhibition in Aortic Stenosis. HTML TitleSALTIRE IIDescriptionBisphosphonates & RANKL inhibition in Aortic StenosisRCT testing whether alendronate & denosumab can slow disease progression in aortic stenosisStatusCompletedPIProf Marc DweckEdinburgh Imaging CollaboratorProf Edwin van BeekDr Mhairi DorisAlison FletcherProf David NewbyDiseaseAortic StenosisFacility / resourceEIF QMRIPET-CTProject typeEME MRC projectFunding Relevant Edinburgh Imaging publications03 May 21. Featured Paper. Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial. This article was published on 2024-08-22
HTML TitleSALTIRE IIDescriptionBisphosphonates & RANKL inhibition in Aortic StenosisRCT testing whether alendronate & denosumab can slow disease progression in aortic stenosisStatusCompletedPIProf Marc DweckEdinburgh Imaging CollaboratorProf Edwin van BeekDr Mhairi DorisAlison FletcherProf David NewbyDiseaseAortic StenosisFacility / resourceEIF QMRIPET-CTProject typeEME MRC projectFunding Relevant Edinburgh Imaging publications03 May 21. Featured Paper. Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial.